Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure: Role of nitric oxide, prostanoids, and oxidant stress

Circulation

Volumn 99, Issue 22, 1999, Pages 2951-2957

  Varin, Rémi ^a   Mulder, Paul ^a   Richard, Vincent ^a   Tamion, Fabienne ^a   Devaux, Corinne ^a   Henry, Jean Paul ^a   Lallemand, Françoise ^a   Lerebours, Guy ^a   Thuillez, Christian ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Dilatation; Exercise; Heart failure; Muscle, skeletal; Nitric oxide synthase; Prostaglandins

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE; MALE; MUSCLE BLOOD FLOW; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033535969     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.22.2951     Document Type: Article

References (33)

1. Ontkean M, Gay R, Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental of model of chronic heart failure. Circ Res. 1991;69:1088-1096.
2. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR. Endothelial function in congestive heart failure. Am Heart J. 1993;126:761-764. Review.
3. Mulder P, Elfertak L, Richard V, Compagnon P, Devaux B, Henry JP, Scalbert E, Desché P, Macé B, Thuillez C. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol. 1996;271:H469-H474.
4. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19:918-925.
5. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596-1601.
6. Lindsay DC, Jiang C, Brunotte F, Adamopoulos S, Coats AJ, Rajagopalan B, Poole-Wilson PA, Collins P. Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res. 1992;26:694-697.
7. Kaiser L, Spickard RC, Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol. 1989;256: H962-H967.
8. Thuillez C, Mulder P, Elfertak L, Blaysat G, Compagnon P, Henry JP, Richard V, Scalbert E, Desché P. Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure: effect of angiotensin converting enzyme inhibition. Am J Hypertens. 1995;8: 7S-12S.
9. Miller VM, Vanhoutte PM. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. Am J Physiol. 1988;255: H446-H451.
10. Arnal JF, Schott C, Stoclet JC, Michel JB. Vascular relaxation and cyclic guanosine monophosphate in a rat model of high output heart failure. Cardiovasc Res. 1993;27:1651-1656.
11. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996;93: 210-214.
12. Pfeffer MA, Pfeffer J, Fishbein M. Myocardial infarct size and ventricular functions in rats. Circ Res. 1979;44:503-512.
13. Mulder P, Richard V, Compagnon P, Henry JP, Lallemand F, Clozel JP, Koen R, Macé B, Thuillez C. Increased survival after chronic treatment with mibefradil, a selective T channels calcium antagonist, in heart failure. J Am Coll Cardiol. 1997;29:416-421.
14. Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Mace B, Comoy E, Letac B, Thuillez C. Role of endogenous endothelin in chronic heart failure: effect of a long term treatment with an endothelin antagonists on survival, hemodynamics and cardiac remodeling. Circulation. 1997;96:1976-1982.
15. Mulder P, Devaux B, Richard V, Henry JP, Wimart MC, Thibout E, Macé B, Thuillez C. Early vs delayed angiotensin converting enzyme inhibition in experimental chronic heart failure: effects on survival, hemodynamics and cardiovascular remodeling. Circulation. 1997;95:1314-1319.
16. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation. 1994;89:345-354.
17. Dohi Y, Thiel MA, Bühler FR, Lüscher TF. Activation of endothelial L-arginine pathway in resistance arteries: effect of age and hypertension. Hypertension. 1990;15:170-179.
18. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
19. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature. 1986; 320:454-460.
20. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard K Jr, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
21. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 1998;97:363-368.
22. Nadaud S, Philippe M, Arnal JF, Michel JB, Soubrier F. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res. 1996;79:857-863.
23. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995;269:C1371-C1378.
24. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular, nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74: 349-353.
25. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor alpha in severe congestive cardiac failure. Br Heart J. 1993;70: 141-143.
26. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
27. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating level of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
28. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209.
29. Musch TI, Tefrell JA. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise. Am J Physiol. 1992;262:H411-H419.
30. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol. 1994;267:H1921-H1927.
31. Niu XF, Smith W, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133-1140.
32. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alteration of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
33. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rats. Hypertension. 1986;8:344-348.djh